Abstracts

ARV Adherence Associated with Reduced Breastmilk HIV Viral Load and HIV Transmission

Background: To prevent mother-to-child HIV transmission, antiretroviral (ARV) interventions have been used to reduce HIV viral replication in breastmilk and maternal blood. Achieving and maintaining viral suppression relies on adherence to ARV regimens. Methods: A case cohort study was conducted using data from the Breastfeeding, Antiretrovirals and Nutrition study to comprehensively assess the role of…

Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation

Background: Insulin resistance and lipid changes are commonly seen after ART initiation. Observational studies suggest that vitamin D supplementation reduces the risk of developing diabetes and improves lipid profiles. Methods: This 48-week prospective, randomized, double-blind, placebo-controlled study evaluated the effect of high dose vitamin D3 (4000 IU daily) plus calcium supplementation (1000 mg calcium carbonate…

Diabetes Mellitus Among HIV-Infected Adults in Care in the United States, 2009–2010

Background: Diabetes mellitus (DM) is increasingly prevalent among the U.S. general adult population, but prevalence estimates among HIV-infected persons, who are living longer, are lacking. Methods: We used 2009-2010 data from the Medical Monitoring Project (MMP) to determine DM prevalence among a nationally representative cross-sectional sample of HIV-infected adults receiving medical care in the United…

Functional Vitamin D Deficiency With Initiation of Tenofovir-Based ART?

Background: Antiretroviral regimens containing tenofovir disoproxil fumarate (TDF) have been associated with decreases in bone mineral density (BMD), and elevations in bone turnover markers (BTM) and intact parathyroid hormone (iPTH) in patients with HIV. Prior cross-sectional studies suggested that a functional vitamin D deficiency may in part explain these changes. To explore this hypothesis further,…

Determinants of Parathyroid Hormone Levels in HIV-positive Tenofovir-treated Patients with Normal Renal Function

Background: Secondary hyperparathyroidism may develop in HIV-positive patients in case of vitamin D deficiency and calcium or phosphorus metabolism disorders. Traditional (age, gender, BMI) and therapeutic determinants [tenofovir (TDF) exposure] have been described but the role of TDF exposure as well as of genetic polymorphisms in key genes is currently unknown. Methods: Adult HIV-positive patients…

Elevated Tenofovir Exposure via Intensive PK Monitoring Is Associated With Progressive Kidney Function Decline

Background: Tenofovir disoproxil fumarate (TDF) is commonly used for HIV treatment, but risk factors for tenofovir (TFV)-associated kidney disease are relatively understudied. Among a diverse cohort of HIV-infected women on TFV-based therapy, we performed intensive pharmacokinetic (PK) studies to measure TFV exposure and assess its association with subsequent kidney function. Methods: The Women’s Interagency HIV…

Impact of TDF+PI/r on Renal Function in Sub-Saharan Africa : 2LADY/ANRS 12169 Trial

Background: A strong genetic susceptibility to chronic kidney disease (CKD) has been observed in sub-Saharan African populations. The current WHO-recommended second line antiretroviral treatment (ART) associates a protease inhibitor boosted with ritonavir (PI/r) in combination with Tenofovir Disoproxil Fumarate (TDF) or Zidovudine (AZT) + lamivudine or emtricitabine (FTC). TDF + PI/r has been associated with…

Renal Tubular Disease and the Relationship With Tenofovir and Atazanavir Exposure

Background: Renal tubular dysfunction is common in HIV+ patients treated with antiretroviral therapy (ART). The pathological spectrum of renal tubular disease (RTD) and its association with ART remains poorly described. Methods: We reviewed 265 consecutive renal biopsies (2000-2012) of HIV+ patients attending 8 clinics in the UK. We describe the clinical characteristics of patients with…